Anavex Life Sciences Corp (AVXL)

[abew4me]

Makes me wonder if this had anything to do with it? (Read both headlines below)

FDA Selects Ariana's KEM Platform for Biomarker Signature Validation

FDA has chosen to implement Ariana Pharma's KEM® (Knowledge Extraction Management) decision-support platform to facilitate data analysis for the validation of biomarker signatures. The technology will be used by FDA's reviewers to analyze pharmacogenomic and other data submitted through the agency's Voluntary Exploratory Data Submission (VXDS) program.

Ariana claims the collaboration will help FDA more systematically identify potential genomic fingerprints and develop recommendations relating to the analysis of genomic data prior to the submission of biomarker signatures. "We are looking forward to this collaboration to help the agency systematically analyze all equivalent signatures combining both genomic and phenotypic data, thus increasing chances of selecting the best biomarker signature," comments Federico Goodsaid, Ph.D., FDA's associate director for operations in genomics at the Center for Drug Evaluation and Research's Office of Clinical Pharmacology.

Ariana provides data-mining solutions and decision-support services for clinical and safety studies, drug discovery, diagnostics, and biomarker development. The firm's KEM platform is a rules-based method developed to mine data and systematically extract and manage all consistent hypotheses. Ariana claims the technology can be applied to biomarker discovery to identify the best subset of markers in order to maximize patient coverage, through the ability to evaluate heterogeneous information, including genomic, proteomic, polypharmacology, and clinical data. The firm also suggests that unlike existing numerical methods, KEM can generate and prioritize hypotheses, carry out more exhaustive analysis, and handle missing data. [From September, 2010]
https://www.genengnews.com/topics/omics/fda-selects-arianas-kem-platform-for-biomarker-signature-validation/
*****************************************************************************************

Anavex Life Sciences and Ariana Pharma Collaborate to Accelerate Timelines and Improve Efficiency
October 5, 2016

[You see, one of the first things Dr. Missling did was to follow the FDA's lead in AI technology...so now both the FDA and Anavex are using Ariana's KEM technology to analyze data. (Not bad for a German, aye?)]

https://www.anavex.com/post/anavex-life-sciences-and-ariana-pharma-collaborate-to-accelerate-timelines-and-improve-efficiency